LAMEA T-Cell therapy Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Cancer Treatment Centers), By Indication (Lymphoma, Acute Lymphocytic Leukemia and Others), By Therapy Type, By Country and Growth Forecast, 2023 - 2030

• Merck KGaA
• Johnson & Johnson
• AbbVie Inc.
• Gilead Sciences Inc.
• Amgen Inc.
• Novartis AG
• Sorrento Therapeutics Inc.
• Bristol Myers Squibb Company
• Immunocore Holdings plc
• Pfizer Inc.